This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Non-valvular Atrial Fibrillation (NVAF)
and you are
over 20
years old
This is an observational trial.
You are contributing to medical knowledge about your condition.
Show me locations

The purpose

The objective of this study is to understand if Rivaroxaban can improve treatment satisfaction of Warfarin patients and assess the safety and effectiveness of Xarelto in real clinical practice. A total of 725 patients are to be enrolled and followed for a 6 months.period. QOL survey will be conducted at month 0, 3, 6 using ACTS/TSQM. This study is categorized as a regulatory post-marketing surveillance in Japan, and it is a local prospective and observational study of patients who have received Xarelto for SPAF.

Provided treatments

  • Drug: Rivaroxaban (Xarelto_ BAY59-7939)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01598051. The sponsor of the trial is Bayer and it is looking for 741 volunteers for the current phase.
Official trial title:
Treatment Satisfaction Under Rivaroxaban (ACTS/TSQM)